Key result
CABG linked to ~19% higher all-cause mortality versus DES-PCI in dialysis patients.
Why the study?
The comparative effectiveness of PCI with drug-eluting stents versus CABG in dialysis patients required evaluation.
Does percutaneous coronary intervention with drug-eluting stent improve survival compared to coronary artery bypass grafting in dialysis patients?
Cohort (n=4,165)
Yes
Does percutaneous coronary intervention with drug-eluting stent improve survival compared to coronary artery bypass grafting in dialysis patients?
In dialysis patients requiring coronary revascularization, PCI with DES is associated with better in-hospital and long-term survival compared to CABG, challenging current guideline suggestions that favor CABG.
Answers are grounded in this paper and cite their sources.
PCI with DES was associated with lower mortality than CABG in dialysis patients; this leaves open selection bias and requires randomized confirmation.
Rationale and Objective To study the comparative effectiveness of percutaneous coronary intervention with drug-eluting stent and coronary artery bypass grafting in dialysis patients. Study Design Retrospective observational cohort study. Setting and Participants This population-based study identified dialysis patients hospitalized for coronary revascularization between January 1, 2009 and December 31, 2015 in Taiwan National Health Insurance Research Database. Exposures Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting. Outcomes All-cause mortality, in-hospital mortality, and repeat revascularization. Analytical Approach Propensity scores were used to match patients. Cox proportional hazards models and logistic regression models were constructed to examine associations between revascularization strategies and mortality. Interval Cox models were fit to estimate time-varying hazards during different periods. Results A total of 1,840 propensity score-matched dialysis patients were analyzed. Coronary artery bypass grafting was associated with higher in-hospital mortality (coronary artery bypass grafting vs. percutaneous coronary intervention with drug-eluting stent, crude mortality rate 12.5% vs. 3.3%; adjusted odds ratio 5.22; 95% confidence interval [CI] 3.42-7.97; p < 0.001), and longer hospitalization duration (median [interquartile range], 20 [14-30] days vs. 3 [2-8] days, p < 0.001). After discharge, repeat revascularization, acute coronary syndrome, and repeat hospitalization all occurred more frequently in the percutaneous coronary intervention with drug-eluting stent group. Importantly, with a median follow-up of 2.8 years, coronary artery bypass grafting was significantly associated with a higher risk of all-cause overall mortality (adjusted hazard ratio 1.19, 95% CI 1.05-1.35, p < 0.01) in the multivariable Cox proportional hazard model. Sensitivity and subgroup analyses yielded consistent results. Limitations Observational study with mainly Asian ethnicity. Conclusions Percutaneous coronary intervention with drug-eluting stent may be associated with better survival than coronary artery bypass grafting in dialysis patients. Future studies are warranted to confirm this finding.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2023) conducted a cohort in End-stage kidney disease on dialysis with coronary artery disease (n=4,165). Coronary artery bypass grafting (CABG) vs. Percutaneous coronary intervention with drug-eluting stent (PCI with DES) was evaluated on All-cause overall mortality (HR 1.19, 95% CI 1.05-1.35, p=< 0.01). Coronary artery bypass grafting was associated with a higher risk of all-cause overall mortality compared to percutaneous coronary intervention with drug-eluting stent in dialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: